# Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)

> **NCT06859931** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Chia Tai Tianqing Pharmaceutical Group Co., Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** TQB3702 Tablets
- **DRUG:** TQB3702 Tablets+TQB3702 Placebo
- **DRUG:** TQB3702 Placebo

## Key facts

- **NCT ID:** NCT06859931
- **Lead sponsor:** Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06859931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06859931, "Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06859931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*